Published in: 01-04-2024 | Media release Palbociclib (Ibrance): risk of venous thromboembolism Published in: Reactions Weekly | Issue 1/2024 Login to get access ExcerptA probable link between the use of palbociclib (Ibrance) and the risk of venous thromboembolism (VTE) has been identified following a safety review by Health Canada. …